Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Launch of quality performance product

26 May 2009 07:00

RNS Number : 7439S
Omega Diagnostics Group PLC
26 May 2009
 



 

Omega Diagnostics Group Plc 

("Omega")

Launch of quality performance product Pathozyme™ ElisaSure

Omega, the AIM listed medical diagnostics company, announces the launch of a new product that checks the quality performance of laboratory equipment and laboratory staff. Pathozyme™ ElisaSure has been specifically designed to test all microtitre plate washers, microplate readers and manual and automated pipetting devices, common items of equipment used in virtually every clinical laboratory worldwide.

 

Laboratories depend on accurate equipment to deliver dependable results day in, day out. To ensure their performance is reproducible within known parameters, between maintenance periods and after repair, this equipment has to be meticulously checked and verified in line with international and national quality standards.

Pathozyme™ ElisaSure allows early detection of deficiencies before any impact is recorded on process reliability. By using the test regularly, documented records can be produced which can serve as evidence of equipment performance and be used to compare current and historical operating levels.

Andrew Shepherd, Chief Executive of Omega, said, 'This new product strengthens our already significant position in the supply of ELISA technology products to the clinical diagnostics market. In an environment of increasing quality monitoring and national and international quality accreditation schemes, we believe that Pathozyme™ ElisaSure is a product that can benefit every laboratory in the world that carries out this type of test. It will be distributed through our worldwide network of distributors that covers over 100 countries".

 

Further enquiries:

Omega Diagnostics Plc

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron HarbinsonGroup Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Nick Wells

Andy Roberts

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFGGZKDZNGLZM
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.